NEWARK, Del., April 14, 2026 /PRNewswire/ — According to a latest market analysis by Future Market Insights, the global CMO/CDMO market is witnessing consistent expansion as pharmaceutical and biotech companies increasingly outsource development and manufacturing to focus on core competencies amid rising drug complexity and cost pressures. The CMO/CDMO Market was valued at USD 4.02 billion in 2025 and is projected to reach USD 5.46 billion by 2035, growing at a CAGR of 3.1% during the forecast period. Demand is being fueled by strong biologics and biosimilars pipelines, regulatory support for accelerated approvals, and the shift toward flexible, tech-enabled, and sustainable manufacturing solutions. Quick Stats: CMO/CDMO Market…